3 Dental Stocks to Buy Now to Keep You Smiling

NASDAQ: ALGN | Align Technology, Inc. News, Ratings, and Charts

ALGN – With more than half of the population in the United States having been at least partly vaccinated for COVID-19 (and almost half fully vaccinated), there has been a substantial uptick in the number of people visiting clinics and hospitals for dental checkups. Furthermore, the increasing use of more efficient and advanced dental equipment, coupled with current government initiatives to boost the healthcare sector, has fostered favorable investor sentiment about the industry’s growth potential. So, we think dental stocks Align Technologies (ALGN), Dentsply Sirona (XRAY), and Henry Schein (HSIC) could be solid bets now. Let’s take a close look at these names.

The COVID-19 pandemic  had a huge, negative impact on  the dental care and services market last year. But the industry is now recovering at a fast pace as solid progress on the vaccination front has been driving a gradual return to in-office dental checkups, which were  deferred for an extended period. In addition, increasing consumer spending and extensive government spending to strengthen healthcare infrastructure are expected to create a conducive environment for further industry growth.

Growing demand for cosmetic dental surgeries, technological advancements, and an aging population are projected to boost the growth of the dental care and services market. The global dental equipment market is expected to reach $5.4 billion by 2028, registering a 12.1% CAGR.

Considering the rapid advancement in dental procedures and substantial rise in dental hygiene appointments, we believe dental companies Align Technologies (ALGN), Dentsply Sirona Inc. (XRAY), and Henry Schein Inc. (HSIC) are well-positioned to witness robust demand for their products and services. Thus, these stocks could be ideal bets now.

Align Technologies Inc. (ALGN)

ALGN, which is based in San Jose, Calif., develops, produces, and sells a system of clear aligner therapy, intra-oral scanners, and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics, and dental records storage. Clear Aligner, and Scanner and Services are the two business segments through which the company operates.

This month, ALGN announced the opening of its new premises in Petach Tikva, Israel, atop one of the three high-rise buildings that make up the “Global Towers.” Through this, the company aims to expand its industry-leading digital capabilities via continuous scanner innovation and solutions and assist more dental professionals across the world in transforming their practices using digital tools and technology.

During the first quarter, ended March 31, 2021, ALGN’s net revenue increased 62.4% year-over-year to $894.78 million. The company’s non-GAAP operating income increased 171.6% year-over-year to $255.79 million over this period. Its non-GAAP net income increased 242.67% year-over-year to $198.4 million, while its non-GAAP EPS grew 241.1% from the prior-year quarter to $2.49.

A $10.4  consensus EPS estimate for the current year represents a 98.1% improvement year-over-year. The  $3.81 billion consensus revenue estimate for the current year represents a 54.2% increase from the same period last year. The stock has gained 113.5% over the past year and 35.9% over the past nine months.

ALGN’s POWR Ratings reflect this promising outlook. The company has an overall B rating, which translates to Buy in our proprietary rating system. The POWR Ratings assess stocks by 118 different factors, each with its own weighting.

ALGN is also rated an A grade for Growth, and a B for Quality and Sentiment. Within the Medical – Devices/Equipment industry, it is ranked #45 of 187 stocks.

To see additional POWR Ratings for Momentum, Stability, and Value for ALGN, click here.

Click here to checkout our Healthcare Sector Report for 2021

Dentsply Sirona Inc. (XRAY)

XRAY is a dental product and technology manufacturer that is based in York, Pa. The company is involved in developing, producing, and selling dental equipment and dental consumables. Technologies & Equipment, and Consumables are the two segments through which the company operates.

Last month, XRAY acquired Propel Orthodontics through an all-cash $131 million deal. With this acquisition,  the company aims to further enhance its position in the fast-growing clear aligner sector.

For the first quarter ended March 31, 2021, XRAY’s non-GAAP net sales increased 17.5% year-over-year to $1.03 billion. The company’s non-GAAP operating income increased 67.2% year-over-year to $219 million. Its net income came in at $117 million for the quarter, compared to a $140 million net loss  in the prior-year quarter. Its non-GAAP EPS increased 67.4% year-over-year to $0.72 over this period.

XRAY is expected to witness 27% revenue growth  for the current year. Its EPS is estimated to increase 60.3% year-over-year to $2.87 in 2021. Over the past year, XRAY’s stock has gained 44.6%. Furthermore, it has gained 21.5% year-to-date.

XRAY’s strong fundamentals are reflected in its POWR Ratings. The stock has an overall A rating, which equates to Strong Buy in our POWR Ratings system. The stock also has an A grade for Growth, and a B for Value and Sentiment. In the Medical – Devices/Equipment  industry, it is ranked #12 of 187 stocks.

In total, we rate XRAY on eight different levels. Beyond what we’ve stated above, we have also given XRAY grades for Stability, Momentum, and Quality. Get all the XRAY ratings here.

Click here to checkout our Healthcare Sector Report for 2021

Henry Schein Inc. (HSIC)

HSIC is involved in providing healthcare services to dental practitioners, laboratories, physician practices, government, and institutional healthcare clinics. The company operates through two segments: Healthcare Distribution and Technology and Value-Added Services. HSIC is based in Melville, N.Y.

Last month, HSIC acquired a 70% stake in eAssist Dental Solutions. The move should  enable the company to achieve its goal of providing best-of-breed solutions to help dental offices operate more smoothly and efficiently, while allowing them to focus more on patient care.

HSIC’s net sales increased 20.4% year-over-year to $2.92 billion in the first quarter ended March 27, 2021. Its gross profit surged 19.4% year-over-year to $890.85 million. The company’s net income increased 27.4% from its  year-ago value to $166 million over this period. And its EPS increased 27.4% year-over-year to $1.16.

The company’s EPS is expected to grow 39.4% year-over-year to $4.14 in the current year. Also,  HSIC has an impressive earnings surprise history; it beat the consensus EPS estimates in each of the trailing four quarters. Analysts expect HSIC’s revenue to increase 16% year-over-year to $11.74 billion in its fiscal year 2021. HSIC’s stock has gained 13.1% over the past year and 15.7% year-to-date.

It is no surprise that HSIC has an overall B rating, which equates to Buy in our POWR Ratings system. The stock also has an A grade for Growth, and B for Value, and Quality. In the Medical – Devices/Equipment industry, it is ranked #30 of 187 stocks.

In addition to the POWR Ratings grades I have just highlighted, one  can see the HSIC rating for Momentum, Stability, and Sentiment here.

Click here to checkout our Healthcare Sector Report for 2021


ALGN shares were trading at $632.56 per share on Monday afternoon, down $5.72 (-0.90%). Year-to-date, ALGN has gained 18.37%, versus a 18.56% rise in the benchmark S&P 500 index during the same period.


About the Author: Pragya Pandey


Pragya is an equity research analyst and financial journalist with a passion for investing. In college she majored in finance and is currently pursuing the CFA program and is a Level II candidate. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
ALGNGet RatingGet RatingGet Rating
XRAYGet RatingGet RatingGet Rating
HSICGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


:  |  News, Ratings, and Charts

2022 Stock Market Outlook

The stock market (SPY) has continued on a bullish path in 2021. Will that continue in 2022? And what could happen to awaken the bear market from hibernation? 40 year investment veteran Steve Reitmeister explores this and more in this early edition of his 2022 Stock Market Outlook. Read on for full details below...

:  |  News, Ratings, and Charts

How Recent Bearish Sentiment Will Impact the Stock Market

Last week, the S&P 500 (SPY) fell during a short trading week. Multiple factors were weighing on investor sentiment. First was September's history for being a weaker month for stock performance. In addition, the previous week's August payrolls miss seemed to linger on investors' minds due to concerns that the delta variant of COVID was slowing the rebound in the economy. The real estate sector led declines as long-term interest rates increased. Consumer staples and utility stocks performed the best. In terms of market cap, the small-cap Russell 2000 Index underperformed the market after two strong weeks of outperforming the larger benchmarks. Growth stocks also outperformed Value stocks. I’ll discuss this and more below…

:  |  News, Ratings, and Charts

How to Turn Low Priced Stocks into BIG Winners?

Some investors are into growth stocks...some prefer value stocks while others are into momentum, income, chart patterns, insider trading and more. But one area that most investors agree upon is the great appeal in buying low priced stocks. Like those under $10 given the potential that prices soar and you easily beat the stock market (SPY). Read on to discover our brand new strategy for selecting low priced stocks that has led to a surprising +62.88% average annual return. Get the rest below...

:  |  News, Ratings, and Charts

3 Growth Stocks You Can Buy at a Reasonable Price

Even with growth stocks falling last week, investors are still pouring money into companies with strong growth potential. When you add in a value component, you get the best of both worlds. That's why investors should consider growth at a reasonable price stocks such as Westlake Chemical Corporation (WLK), ManpowerGroup (MAN), AutoNation, Inc. (AN).

:  |  News, Ratings, and Charts

How to Turn Low Priced Stocks into BIG Winners?

Some investors are into growth stocks...some prefer value stocks while others are into momentum, income, chart patterns, insider trading and more. But one area that most investors agree upon is the great appeal in buying low priced stocks. Like those under $10 given the potential that prices soar and you easily beat the stock market (SPY). Read on to discover our brand new strategy for selecting low priced stocks that has led to a surprising +62.88% average annual return. Get the rest below...

Read More Stories

More Align Technology, Inc. (ALGN) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All ALGN News